US 11732041
Antibodies against 4G7-derived chimeric antigen receptors
granted A61KA61K40/11A61K40/31
Quick answer
US patent 11732041 (Antibodies against 4G7-derived chimeric antigen receptors) held by Allogene Therapeutics, Inc. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/4211